Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
19/04 | 6,720 USD
-2,75% |
-2,75% |
C4X Discovery Holdings plc |
19/04 | 8,225 GBX
-3,80% |
-3,80% |
|
Cabaletta Bio Inc |
19/04 | 13,340 USD
-4,51% |
-4,51% |
|
Calithera Biosciences Inc |
18/04 | 0,025 USD
-37,38% |
-37,38% |
|
Calliditas Therapeutics AB |
19/04 | 18,700 USD
+5,95% |
+5,95% |
|
Cambridge Cognition Holdings plc |
19/04 | 52,000 GBX
0,00% |
0,00% |
|
Can B Corp |
19/04 | 0,035 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
19/04 | 1,980 USD
+0,51% |
+0,51% |
|
Capricor Therapeutics Inc |
19/04 | 5,010 USD
-0,79% |
-0,79% |
|
Cara Therapeutics Inc |
19/04 | 0,661 USD
-4,20% |
-4,20% |
Carbios |
19/04 | 19,180 EUR
+3,12% |
+3,12% |
Cardiol Therapeutics Inc - Class A |
19/04 | 2,470 CAD
+5,56% |
+5,56% |
|
Cardiovascular Systems Inc. |
27/04 | 20,000 USD
+0,15% |
+0,15% |
|
Caredx Inc |
19/04 | 8,310 USD
+2,97% |
+2,97% |
|
Carisma Therapeutics, Inc. |
19/04 | 1,630 USD
-4,68% |
-4,68% |
|
Carmat |
19/04 | 3,805 EUR
+0,13% |
+0,13% |
|
CASI Pharmaceuticals Inc |
19/04 | 2,250 USD
+0,45% |
+0,45% |
|
Cassava Sciences Inc |
19/04 | 19,640 USD
-7,31% |
-7,31% |
|
Castle Biosciences Inc |
19/04 | 19,310 USD
+0,57% |
+0,57% |
|
Catalent Inc. |
19/04 | 55,480 USD
-0,57% |
-0,57% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
|
Catalyst Pharmaceuticals Inc |
19/04 | 15,130 USD
-1,37% |
-1,37% |
|
Ceapro Inc. |
19/04 | 0,245 CAD
-2,00% |
-2,00% |
|
Cel-Sci Corp. |
19/04 | 1,560 USD
+4,00% |
+4,00% |
|
Celldex Therapeutics Inc. |
19/04 | 37,980 USD
-1,43% |
-1,43% |
|
Cellectar Biosciences Inc |
19/04 | 3,030 USD
-0,33% |
-0,33% |
|
Cellectis |
19/04 | 2,550 USD
+3,24% |
+3,24% |
|
Cellectis |
19/04 | 2,390 EUR
+1,06% |
+1,06% |
Celyad Oncology |
19/04 | 0,340 EUR
+4,29% |
+4,29% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
|
Cerus Corp. |
19/04 | 1,680 USD
+2,44% |
+2,44% |
|
Champions Oncology Inc |
19/04 | 5,060 USD
-0,10% |
-0,10% |
|
Charlottes Web Holdings Inc |
19/04 | 0,305 CAD
+7,02% |
+7,02% |
|
Check-Cap Ltd |
19/04 | 2,260 USD
0,00% |
0,00% |
|
Checkpoint Therapeutics Inc |
19/04 | 1,460 USD
-8,75% |
-8,75% |
|
Chembio Diagnostics Inc. |
27/04 | 0,455 USD
+0,22% |
+0,22% |
|
Chimerix Inc |
19/04 | 0,884 USD
-5,14% |
-5,14% |
|
China Pharma Holdings Inc. |
19/04 | 0,320 USD
-3,03% |
-3,03% |
|
China SXT Pharmaceuticals Inc |
19/04 | 1,020 USD
+3,03% |
+3,03% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
19/04 | 0,681 USD
-5,68% |
-5,68% |
|
Cipher Pharmaceuticals Inc |
19/04 | 8,500 CAD
-3,35% |
-3,35% |
|
Citius Pharmaceuticals Inc |
19/04 | 0,754 USD
-6,34% |
-6,34% |
|
Clean Air Metals Inc |
19/04 | 0,055 CAD
0,00% |
0,00% |
|
ClearPoint Neuro Inc |
19/04 | 5,330 USD
-1,11% |
-1,11% |
|
Clearside Biomedical Inc |
19/04 | 1,310 USD
-0,76% |
-0,76% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Cns Pharmaceuticals Inc |
19/04 | 0,202 USD
-0,98% |
-0,98% |
|
Co-Diagnostics Inc |
19/04 | 1,150 USD
-0,86% |
-0,86% |
|
Cocrystal Pharma Inc |
19/04 | 1,530 USD
+2,33% |
+2,33% |
|
Codiak Biosciences Inc |
4/04 | 0,057 USD
0,00% |
0,00% |
|
Cogent Biosciences Inc |
19/04 | 6,710 USD
+1,51% |
+1,51% |
|
CohBar Inc |
19/04 | 0,900 USD
+0,01% |
+0,01% |
|
Coherus Biosciences Inc |
19/04 | 2,070 USD
+3,50% |
+3,50% |
|
Collegium Pharmaceutical Inc |
19/04 | 34,840 USD
+0,20% |
+0,20% |
|
CollPlant Biotechnologies Ltd |
19/04 | 5,200 USD
-0,38% |
-0,38% |
Coloplast |
19/04 | 906,000 DKK
+1,09% |
+1,09% |
|
Compass Pathways Plc |
19/04 | 8,380 USD
-0,48% |
-0,48% |
|
Compass Therapeutics Inc |
19/04 | 1,470 USD
-1,34% |
-1,34% |
|
Compugen Ltd. |
19/04 | 1,900 USD
+1,06% |
+1,06% |
|
Concert Pharmaceuticals Inc |
4/04 | 8,370 USD
0,00% |
0,00% |
|
Condor Technologies |
29/02 | 12,000 EUR
-4,00% |
-4,00% |
|
Conformis Inc. |
1/09 | 2,260 USD
0,00% |
0,00% |
|
Conmed Corp. |
19/04 | 72,640 USD
+2,19% |
+2,19% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Convatec Group |
19/04 | 282,600 GBX
-0,35% |
-0,35% |
|
Cooper Companies, Inc. |
19/04 | 90,420 USD
+0,01% |
+0,01% |
|
Cooper Companies, Inc. |
19/04 | 90,420 USD
+0,01% |
+0,01% |
|
Corbus Pharmaceuticals Holdings Inc |
19/04 | 39,240 USD
+7,42% |
+7,42% |
|
Corcept Therapeutics Inc |
19/04 | 22,950 USD
+1,28% |
+1,28% |
|
CorMedix Inc |
19/04 | 5,280 USD
-2,58% |
-2,58% |
|
Corvus Pharmaceuticals Inc |
19/04 | 1,400 USD
-0,71% |
-0,71% |
|
Covalon Technologies Ltd. |
19/04 | 1,090 CAD
-9,17% |
-9,17% |
|
Creo Medical Group Plc |
19/04 | 34,750 GBX
+0,72% |
+0,72% |
|
Crescita Therapeutics Inc |
19/04 | 0,435 CAD
0,00% |
0,00% |
|
Crinetics Pharmaceuticals Inc |
19/04 | 42,970 USD
-0,09% |
-0,09% |
|
CRISPR Therapeutics AG |
19/04 | 55,050 USD
-1,98% |
-1,98% |
|
Cronos Group Inc |
19/04 | 2,370 USD
-1,66% |
-1,66% |
|
Crossject |
19/04 | 2,060 EUR
+0,98% |
+0,98% |
|
Cryo-Cell International, Inc. |
19/04 | 7,500 USD
+1,76% |
+1,76% |
|
CTI BioPharma Corp |
23/06 | 9,090 USD
0,00% |
0,00% |
|
Cue Biopharma Inc |
19/04 | 1,560 USD
-1,27% |
-1,27% |
|
Cumberland Pharmaceuticals Inc. |
19/04 | 1,600 USD
-3,03% |
-3,03% |
|
CureVac N.V. |
19/04 | 2,440 USD
0,00% |
0,00% |
|
Curis Inc |
19/04 | 14,310 USD
-5,98% |
-5,98% |
|
Cutera Inc |
19/04 | 1,950 USD
-15,22% |
-15,22% |
|
Cyanotech Corp. |
19/04 | 0,351 USD
+6,21% |
+6,21% |
|
Cyclacel Pharmaceuticals Inc |
19/04 | 1,780 USD
-3,78% |
-3,78% |
|
Cyclacel Pharmaceuticals Inc |
19/04 | 13,000 USD
-26,35% |
-26,35% |
|
Cyclerion Therapeutics Inc |
19/04 | 3,500 USD
+8,76% |
+8,76% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
19/04 | 67,550 USD
+0,82% |
+0,82% |
|
CytomX Therapeutics Inc |
19/04 | 1,670 USD
-3,47% |
-3,47% |
|
Cytosorbents Corp |
19/04 | 0,802 USD
+0,12% |
+0,12% |
Cytotools AG |
19/04 | 0,470 EUR
0,00% |
0,00% |
Nieuws over “Gezondheidstechnologie”
